Cardinal Health Stock-Based Comp increased by 48.3% to $129.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 316.1%, from $31.00M to $129.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 28.7% CAGR.
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
stock_based_compensation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.00M | $24.00M | $18.00M | $23.00M | $16.00M | $23.00M | $25.00M | $21.00M | $27.00M | $29.00M | $28.00M | $31.00M | $33.00M | $30.00M | $30.00M | $31.00M | $153.00M | $93.00M | $87.00M | $129.00M |
| QoQ Change | — | +380.0% | -25.0% | +27.8% | -30.4% | +43.8% | +8.7% | -16.0% | +28.6% | +7.4% | -3.4% | +10.7% | +6.5% | -9.1% | +0.0% | +3.3% | +393.5% | -39.2% | -6.5% | +48.3% |
| YoY Change | — | — | — | — | +220.0% | -4.2% | +38.9% | -8.7% | +68.8% | +26.1% | +12.0% | +47.6% | +22.2% | +3.4% | +7.1% | +0.0% | +363.6% | +210.0% | +190.0% | +316.1% |